Beta Drugs Limited issued a corrigendum to its Extra Ordinary General Meeting notice scheduled for November 12, 2024, providing clarifications on specific points related to the preferential issue of equity shares, detailing an estimated total fund utilization of INR 117 crore for various purposes.